Objectives Sedation has been established for GI endoscopic procedures in most countries, but it is also associated with an added risk of complications. Reported complication rates are variable due to different study methodologies and often limited sample size.
Designs Acute sedation-associated complications were prospectively recorded in an electronic endoscopy documentation in 39 study centres between December 2011 and August 2014 (median inclusion period 24 months). The sedation regimen was decided by each study centre.
Results A total of 368 206 endoscopies was recorded; 11% without sedation. Propofol was the dominant drug used (62% only, 22.5% in combination with midazolam). Of the sedated patients, 38 (0.01%) suffered a major complication, and overall mortality was 0.005% (n=15); minor complications occurred in 0.3%. Multivariate analysis showed the following independent risk factors for all complications: American Society of Anesthesiologists class >2 (OR 2.29) and type and duration of endoscopy. Of the sedation regimens, propofol monosedation had the lowest rate (OR 0.75) compared with midazolam (reference) and combinations (OR 1.0–1.5). Compared with primary care hospitals, tertiary referral centres had higher complication rates (OR 1.61). Notably, compared with sedation by a two-person endoscopy team (endoscopist/assistant; 53.5% of all procedures), adding another person for sedation (nurse, physician) was associated with higher complication rates (ORs 1.40–4.46), probably due to higher complexity of procedures not evident in the multivariate analysis.
Conclusions This large multicentre registry study confirmed that severe acute sedation-related complications are rare during GI endoscopy with a very low mortality. The data are useful for planning risk factor-adapted sedation management to further prevent sedation-associated complications in selected patients.
Trial registration number DRKS00007768; Pre-results.
- cardiovascular complications
- gastrointesinal endoscopy
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Contributors AB planned the study, did the study organisation, was involved in data collection, prepared the manuscript, was involved in thestatistical analysis and submitted the study. CE planned the study, was involved in data collection and study organisation, prepared the manuscript and was involved in the statistical analysis. WR, CF, SP and AA were involved indata collection. AK, HM, HK, CS, AL, MP, J-UJ, CvT, ME, MS, MK, DS, WH, OE, OP, FK, BL, UW, DS, SB, SuB, VC, JFE, FLD, CB, TR, GH, MB, CRdM, GK, CP, CV, RK, WF, IK, JK, MB, NLS, AM, RV, RP, ME, WS, MD, WSch, AD and VS were involved in data collection and in manuscript creation. JL was involved in manuscript creation. GK and AK were involved in the statistical analysis. NB was involved in creating figures.
Competing interests None declared.
Ethics approval Ethics Committee of the Medical Council of the state of Hesse (FF 8/2012) on 13 April 2011.
Provenance and peer review Not commissioned; externally peer reviewed.